Mifepristone approval/access has grown in so many ways:
- Globally access improved
- Indications for use expanded
- Methods of delivery expanding (telemedicine, meds by mail)
In Europe, Germany had the lowest uptake of medication abortion. This might be due to low reimbursement for simple and safe care in Germany and medication abortion is so safe!
COVID catapulted telemedicine services. This has helped with myth busting. Now we know:
- Availability of medication abortion did NOT increase abortion rates
- People WANT to have abortions at home
- Medication abortion is so SAFE it does not require physician CONTROL
But do not be fooled: approval of mifepristone does not equal access. Access is limited by
- Governments (REMS, ultrasound req's)
- Providers (conscientious refusals, unnecessary tests/visits/ultrasounds
- Commercial entities (pricing, competition advertising)
What do people need to have a safe medication abortion?
ONLY 3 THINGS: 1) The correct meds in the correct doses 2) The instructions for how to use the meds 3) Information on where to go/whom to contact if they have problems/concerns
How can we increase access and use?
- No test medication abortion
- Telemedicine
- Access to the market for pills with no impediments
- Self led administration of drugs
- Self confirmation of success
Over-medicalization of medication abortion contributes to cost and barriers to care. For example, there is no reimbursement for medication abortion provision in CA unless there is a follow up appointment.
Medication abortion is victim to a dogma in medicine where there is resistance to de-escalate interventions. We use interventions as security blankets and this is not patient centered.
Barriers to accessing medication abortion in Texas even before #SB8:
- 24hr mandatory delay ("wait period") for care
- Both mifepristone and misoprostol had to be administered in clinic by a physician
- Mandatory follow up at 7 days (not evidence based timeline)
Alamo Clinic moved from TX to NM and was able to practice evidence based care without government interference. Follow up for medication abortion is #patientcentered:
- Phone call in 1 week
- Possible ultrasound
- Home UPT
- Serum HCG
People in TX have been seeking care after medication abortion at:
- Private physicians (maybe informants, may not "want" risk of post-abortion care)
- Planned Parenthood
- Crisis pregnancy centers (abundant but problematic for shaming and policing patients)
While medication abortion failure is uncommon, if you live in TX and go to NM, failure could cost:
- 26 hr drive costing $240 in gas or 4 hour flight costing $420 in airfare
- Missed work/childcare
- DISTRESS
Interstate abortion care is not set up to follow or trend beta HCG across institutions, let alone state lines. This shifts the "responsibility" to the patient and is a huge burden emotionally, financially and possibly legally.
The program @AyaContigo is in Venezuela as a mobile abortion doula. Advantages include:
- Off line capability
- Live chat features from counselors from Venezuela
- Compatibility with @WhatsApp
@AyaContigo is proof that there are local solutions which can offer user-centered community led design. Digital health reduces cost & accelerate distribution of trusted resources.
This is an example of a community in crisis leading the medical field.
These lessons have impact in well resourced settings! @VitalaGlobal has created the resource mypostcare.ca which gives evidence based resources for medication abortion support for people in Canada.
Audience: Monitoring outcomes if fundamental to ethical medical care. How can we monitor complications/outcomes as we embrace "less is more" with medication abortion?
Panel: What are real complications (ectopic) vs perceived complications? What matters to patients?
Bottom line for medication abortion: We are beyond safety and effectiveness. We need to be asking how we provide a quality abortion experience for patients.
Where you train is where you work. Half of physicians stay in the states where they do their residency, so there is unlikely to be spontaneous sharing of abortion knowledge across communities. Healthcare inequities will continue to rise.
While this panel will focus on medical specialities, including OBGYNS and FM residents who are some of the most diverse subspecialties, there are so many trainees impacted by abortion restrictions including @ACNMmidwives and @GeneticCouns not to mention Pediatric and EM
Speaker Alejandra Pablos shares her story #KeepAleFree and encourages others to do so too through @AbortionStories. She says her story of fighting deportation, being detained and says that fighting for abortion rights are an intuitive extension of her goals and values.
Dr. Perritt @Reprorightsdoc encourages the audience to center on their own positionality. We focus on disclosures in medicine, but positionality - where we grew up, who we are, how the world sees us - are probably more important in framing our actions.
Speakers are from @PPFA where they lead the strategy and content that aims to to increase inclusivity and culturally appropriate care among Spanish speaking populations
They recognize that this is a HUGE task because of the immense diversity among Latinx populations. However, they report that language can be unifying across these cultural differences.
Dr. Henkle: Breast engorgement after 2nd trimester abortion is common, under appreciated and under treated. There is poor evidence for non pharmacologic interventions (cabbage leaves). CABERGOLINE is a safe, well tolerated treatment to prevent this. Downside: COST